1Life Healthcare, Inc. (NASDAQ:ONEM) Receives $22.77 Consensus Price Target from Analysts

1Life Healthcare, Inc. (NASDAQ:ONEMGet Rating) has received an average rating of “Buy” from the seventeen analysts that are currently covering the company, Marketbeat Ratings reports. Four equities research analysts have rated the stock with a hold recommendation and ten have given a buy recommendation to the company. The average twelve-month price objective among brokers that have updated their coverage on the stock in the last year is $22.93.

A number of research firms have recently commented on ONEM. Zacks Investment Research cut shares of 1Life Healthcare from a “buy” rating to a “hold” rating in a research note on Tuesday. Piper Sandler cut their target price on shares of 1Life Healthcare from $37.00 to $20.00 and set an “overweight” rating for the company in a research note on Thursday, February 24th. William Blair reaffirmed an “outperform” rating on shares of 1Life Healthcare in a research note on Thursday, March 10th. Citigroup dropped their price objective on shares of 1Life Healthcare from $17.00 to $14.00 in a research note on Thursday, May 5th. Finally, Canaccord Genuity Group dropped their price objective on shares of 1Life Healthcare from $18.00 to $14.00 and set a “buy” rating for the company in a research note on Thursday, May 5th.

Shares of 1Life Healthcare stock traded down $0.09 during trading hours on Thursday, reaching $6.64. The stock had a trading volume of 3,040,056 shares, compared to its average volume of 2,638,141. The firm has a market capitalization of $1.29 billion, a PE ratio of -3.78 and a beta of 1.87. The stock’s 50 day moving average is $9.59 and its 200 day moving average is $13.52. The company has a current ratio of 3.03, a quick ratio of 3.00 and a debt-to-equity ratio of 0.18. 1Life Healthcare has a twelve month low of $6.05 and a twelve month high of $39.28.

1Life Healthcare (NASDAQ:ONEMGet Rating) last released its earnings results on Wednesday, May 4th. The company reported ($0.47) EPS for the quarter, topping analysts’ consensus estimates of ($0.49) by $0.02. The business had revenue of $254.10 million during the quarter, compared to analysts’ expectations of $246.57 million. 1Life Healthcare had a negative net margin of 40.50% and a negative return on equity of 23.03%. The company’s quarterly revenue was up 109.4% on a year-over-year basis. During the same quarter in the previous year, the company earned ($0.29) earnings per share. As a group, sell-side analysts predict that 1Life Healthcare will post -1.93 earnings per share for the current year.

Several institutional investors have recently bought and sold shares of ONEM. Morgan Stanley lifted its holdings in shares of 1Life Healthcare by 27.5% in the 2nd quarter. Morgan Stanley now owns 1,158,115 shares of the company’s stock worth $38,287,000 after acquiring an additional 250,082 shares during the last quarter. SG Americas Securities LLC lifted its holdings in shares of 1Life Healthcare by 259.6% in the 3rd quarter. SG Americas Securities LLC now owns 48,234 shares of the company’s stock worth $977,000 after acquiring an additional 34,822 shares during the last quarter. Los Angeles Capital Management LLC lifted its holdings in shares of 1Life Healthcare by 58.3% in the 3rd quarter. Los Angeles Capital Management LLC now owns 45,262 shares of the company’s stock worth $917,000 after acquiring an additional 16,664 shares during the last quarter. Swiss National Bank lifted its holdings in shares of 1Life Healthcare by 0.7% in the 3rd quarter. Swiss National Bank now owns 182,200 shares of the company’s stock worth $3,690,000 after acquiring an additional 1,200 shares during the last quarter. Finally, Principal Financial Group Inc. lifted its holdings in shares of 1Life Healthcare by 2.8% in the 3rd quarter. Principal Financial Group Inc. now owns 52,110 shares of the company’s stock worth $1,055,000 after acquiring an additional 1,405 shares during the last quarter. 85.50% of the stock is owned by institutional investors and hedge funds.

1Life Healthcare Company Profile (Get Rating)

1Life Healthcare, Inc operates a membership-based primary care platform under the One Medical brand. The company has developed a healthcare membership model based on direct consumer enrollment, as well as third-party sponsorship. Its membership model includes seamless access to 24/7 digital health services paired with inviting in-office care routinely covered under health insurance programs.

Further Reading

Analyst Recommendations for 1Life Healthcare (NASDAQ:ONEM)

Receive News & Ratings for 1Life Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 1Life Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.